Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching
Journal of Antimicrobial Chemotherapy · 05.05.2026 · 81 (6)
DOI: 10.1093/jac/dkag044 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 12.05.2026. Verfasst von Murat Özdede und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye. Hauptthemen laut MEDLINE: Polymyxin B, Colistin, Anti-Bacterial Agents, Acute Kidney Injury. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Polymyxins are last-resort antibiotics for multidrug-resistant Gram-negative infections, but their nephrotoxicity limits clinical use.
Objectives
To compare the nephrotoxicity of colistin versus polymyxin B and identify risk factors for acute kidney injury (AKI).
Methods
We retrospectively analysed 258 patients (132 colistin, 126 polymyxin B) with normal to moderately impaired renal function. Machine learning (ML) algorithms predicted AKI risk, and propensity score matching was used to evaluate the risk of colistin preference over polymyxin B.
Results
Colistin nephrotoxicity (defined as at least stage II KDIGO AKI) was significantly more frequent with colistin than polymyxin B in both unmatched (for colistin 31% versus for polymyxin B 19%, P = 0.04) and matched cohorts (34.4% for colistin versus 14.1% for polymyxin B, P = 0.01). ML identified lower baseline eGFR, higher uric acid, hypalbuminaemia, higher age, concomitant nephrotoxic drug use, weight, vasopressor use and polymyxin type as top predictors. Colistin preference over polymyxin B resulted in significant nephrotoxicity risk in both unmatched (OR: 2.08, 95% CI [1.14–3.79]) and matched cohorts (OR: 3.42, 95% CI [1.38–8.5]). Complete renal recovery occurred in only 41% of AKI cases within 30 days.
Conclusions
Colistin demonstrates significantly higher nephrotoxicity than polymyxin B. The complex relationship between baseline renal function and AKI risk suggests careful monitoring for patients with moderate renal impairment, regardless of polymyxin choice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
- School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, UK.
- Department of Clinical Pharmacy, Gazi University Faculty of Pharmacy, Ankara, Türkiye.
- Department of Clinical Pharmacy, Hacettepe University Faculty of Pharmacy, Ankara, Türkiye.
- Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
ORCID-Profile: Murat Özdede, Gökhan Metan
Zitieren
APA
Özdede, M., Balli Turhan, F. N., Geridönmez, Ö., Kara, E., & Metan, G. (2026). Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching. Journal of Antimicrobial Chemotherapy, 81(6). https://doi.org/10.1093/jac/dkag044
Vancouver
Özdede M, Balli Turhan FN, Geridönmez Ö, Kara E, Metan G. Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching. Journal of Antimicrobial Chemotherapy. 2026;81(6). doi:10.1093/jac/dkag044
BibTeX
@article{zdede2026,
author = {Özdede, Murat and Balli Turhan, Fatma Nisa and Geridönmez, Özgenur and Kara, Emre and Metan, Gökhan},
title = {Comparative nephrotoxicity of polymyxin B versus colistin: evidence from ensemble learning and propensity score matching},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2026},
volume = {81},
number = {6},
doi = {10.1093/jac/dkag044}
}
EUVIMED